Fig. 3From: Evaluating the effect of recombinant human growth hormone treatment on sleep-related breathing disorders in toddlers with Prader–Willi syndrome: a one-year retrospective cohort studyData of the PSG assessments in the rhGH group and the non-rhGH treatment group. No significant difference was found between rhGH group and the non-rhGH group in OAHI, OAI, ODI and time of SpO2 lower than 90%. ns: no significanceBack to article page